ZyVersa Therapeutics Inc (ZVSA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.625 | -0.077 | -151.111 |
Return on Equity (%) | 21.346 | -0.154 | -191.889 |
Return on Invested Capital (%) | 19.021 | 21.029 | -38.929 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 29.706 | -0.629 | -0.141 |
Earnings Per Share | -0.097 | -0.004 | -1.984 |
Cash Per Share | 0.375 | 0.31 | 0.059 |
Working Capital Per Share | 0.365 | -0.096 | -0.128 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -0.097 | -0.043 | -2.012 |
EBITDA Per Share | -0.097 | -0.043 | -2.012 |
Free Cash Flow Per Share | -0.097 | -0.004 | -1.984 |
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Actions en circulation | 318k | 9,02M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||||||
Actions en circulation | 8,09M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,77M |
Ratio cours/bénéfice | -0,5 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 16,81 |
Ratio prix/valeur comptable | 4,76 |
Rendement de dividende | - |
Actions en circulation | 2,34M |
Volume moyen (1 semaine) | 89,05k |
Volume moyen (1 mois) | 174,41k |
Variation sur 52 semaines | -83,44% |
Plus haut sur 52 semaines | 25,00 |
Plus bas sur 52 semaines | 0,9801 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales